Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta‐analysis
Epilepsia Open · 2023-06 · 8 (2) · 268-277
DOI: 10.1002/epi4.12703 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Epilepsia Open, online erschienen am 14.03.2023. Verfasst von Zhao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Vigabatrin, Spasms, Infantile. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
This systematic review and meta‐analysis aimed to evaluate the efficacy of vigabatrin (VGB) in treating infantile epileptic spasms syndrome (IESS). Databases of PubMed, Embase, Web of Science, MEDLINE, and Cochrane Library were systematically searched. All the relevant randomized controlled trials (RCTs) and observational studies (OSs) of VGB for IESS were included and analyzed separately. The primary outcome was the cessation of epileptic spasms (ES). Five RCTs and nine OSs compared the efficacy of VGB vs hormonal monotherapy for IESS. Meta‐analysis of the five RCTs showed that hormonal monotherapy was significantly better than VGB monotherapy (OR = 0.37, 95% CI = 0.20‐0.67) for patients with new‐onset IESS. Meta‐analysis of the nine OSs agrees with the result from RCTs (OR = 0.61, 95% CI = 0.43‐0.85). VGB was more effective in patients with TSC than in those with other etiologies (five OSs, OR = 5.59, 95% CI = 2.17‐14.41). There was no significant difference in the efficiency of VGB combined with hormonal therapy vs hormonal monotherapy for IESS (two RCTs, OR = 0.75, 95% CI = 0.09‐6.45). Hormonal monotherapy is better than VGB monotherapy for non‐TSC‐associated IESS. But for patients with IESS due to TSC, VGB is the first choice. VGB combined with hormone therapy does not definitely increase ES control rates compared with that of hormonal monotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Peking University First Hospital, Beijing, China.
ORCID-Profile: Zhao Xu, Zhixian Yang
Förderung
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Xu, Z., Gong, P., Jiao, X., Niu, Y., Wu, Y., Zhang, Y., Chang, X., & Yang, Z. (2023). Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta‐analysis. Epilepsia Open, 8(2), 268-277. https://doi.org/10.1002/epi4.12703
Vancouver
Xu Z, Gong P, Jiao X, Niu Y, Wu Y, Zhang Y, et al. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta‐analysis. Epilepsia Open. 2023;8(2):268-277. doi:10.1002/epi4.12703
BibTeX
@article{Xu2023,
author = {Xu, Zhao and Gong, Pan and Jiao, Xianru and Niu, Yue and Wu, Ye and Zhang, Yuehua and Chang, Xingzhi and Yang, Zhixian},
title = {Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta‐analysis},
journal = {Epilepsia Open},
year = {2023},
volume = {8},
number = {2},
pages = {268--277},
doi = {10.1002/epi4.12703}
}
EUVIMED